MX2022015439A - Materiales y metodos para inhibir una infeccion virica, incluida una infeccion por coronavirus. - Google Patents
Materiales y metodos para inhibir una infeccion virica, incluida una infeccion por coronavirus.Info
- Publication number
- MX2022015439A MX2022015439A MX2022015439A MX2022015439A MX2022015439A MX 2022015439 A MX2022015439 A MX 2022015439A MX 2022015439 A MX2022015439 A MX 2022015439A MX 2022015439 A MX2022015439 A MX 2022015439A MX 2022015439 A MX2022015439 A MX 2022015439A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- infection
- inhibiting
- materials
- coronavirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063035733P | 2020-06-06 | 2020-06-06 | |
| PCT/US2021/036104 WO2021248111A1 (en) | 2020-06-06 | 2021-06-07 | Materials and methods for inhibiting a viral infection, including a coronavirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022015439A true MX2022015439A (es) | 2023-03-22 |
Family
ID=78831585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022015439A MX2022015439A (es) | 2020-06-06 | 2021-06-07 | Materiales y metodos para inhibir una infeccion virica, incluida una infeccion por coronavirus. |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11826390B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4161558A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023529152A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230025853A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116133669A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021286002A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022024911A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3180737A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL298401A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022015439A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021248111A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL293368B2 (en) * | 2019-11-26 | 2026-05-01 | Quorum Innovations Llc | New barrier and protective preparations and their use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002951270A0 (en) * | 2002-09-06 | 2002-09-19 | Vri Biomedical Ltd | Probiotic Bacterium and Methods of Use |
| KR101300086B1 (ko) | 2005-10-06 | 2013-08-30 | 프로비 아베 | 자가면역질환의 치료를 위한 락토바실러스의 용도 |
| AU2008361375B2 (en) * | 2008-09-04 | 2014-05-22 | Om Pharma | Immunomodulatory extracts from Lactobacillus bacteria and methods of manufacturing and use thereof |
| WO2012141540A2 (ko) * | 2011-04-13 | 2012-10-18 | 씨제이제일제당 (주) | 바이러스 감염 억제 활성을 갖는 신규 분리한 락토바실러스 퍼멘텀 균주 |
| WO2017015275A1 (en) * | 2015-07-20 | 2017-01-26 | Quorum Innovations, Llc | Materials and methods for improving immune responses and the skin and/or mucosal barrier function |
| CN109562140B (zh) | 2016-06-03 | 2023-01-03 | 霍夫耳科研究所 | 用于内耳感觉毛细胞再生/替换的联合疗法 |
| US12195502B2 (en) * | 2020-05-06 | 2025-01-14 | Quorum Innovations, Llc | Protein, and therapeutic and cosmetic uses thereof |
-
2021
- 2021-06-07 CN CN202180059965.6A patent/CN116133669A/zh active Pending
- 2021-06-07 JP JP2022574660A patent/JP2023529152A/ja not_active Withdrawn
- 2021-06-07 EP EP21816956.3A patent/EP4161558A4/en not_active Withdrawn
- 2021-06-07 IL IL298401A patent/IL298401A/en unknown
- 2021-06-07 CA CA3180737A patent/CA3180737A1/en active Pending
- 2021-06-07 AU AU2021286002A patent/AU2021286002A1/en not_active Abandoned
- 2021-06-07 US US17/418,440 patent/US11826390B2/en active Active
- 2021-06-07 BR BR112022024911A patent/BR112022024911A2/pt unknown
- 2021-06-07 WO PCT/US2021/036104 patent/WO2021248111A1/en not_active Ceased
- 2021-06-07 KR KR1020237000014A patent/KR20230025853A/ko not_active Ceased
- 2021-06-07 MX MX2022015439A patent/MX2022015439A/es unknown
-
2023
- 2023-10-25 US US18/493,979 patent/US12653849B2/en active Active
-
2026
- 2026-03-20 US US19/573,821 patent/US20260224649A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230025853A (ko) | 2023-02-23 |
| WO2021248111A9 (en) | 2022-12-22 |
| US20230136276A1 (en) | 2023-05-04 |
| AU2021286002A1 (en) | 2023-01-19 |
| EP4161558A4 (en) | 2024-06-19 |
| US20260224649A1 (en) | 2026-08-06 |
| IL298401A (en) | 2023-01-01 |
| WO2021248111A1 (en) | 2021-12-09 |
| EP4161558A1 (en) | 2023-04-12 |
| US12653849B2 (en) | 2026-06-16 |
| JP2023529152A (ja) | 2023-07-07 |
| US20240075083A1 (en) | 2024-03-07 |
| CA3180737A1 (en) | 2021-12-09 |
| US11826390B2 (en) | 2023-11-28 |
| CN116133669A (zh) | 2023-05-16 |
| BR112022024911A2 (pt) | 2022-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021188969A3 (en) | Coronavirus vaccines and methods of use | |
| CY1118006T1 (el) | Χρηση γαλακτοβακιλλων για την αγωγη ιικων λοιμωξεων | |
| MX379160B (es) | Bifidobacterium longum capaz de modular beneficiosamente la respuesta inmune contra una infección respiratoria por virus. | |
| MX2023009527A (es) | Degradadores de la cinasa 4 asociada al receptor de interleucina 1 (irak4) y usos de los mismos. | |
| WO2004069156A3 (en) | Inactivated probiotic bacteria and methods of use thereof | |
| HUP9802525A1 (hu) | Hüvelyfertőzések kezelésére szolgáló, lactobacillus tartalmú gyógyászati készítmények | |
| MX2025000629A (es) | Cepas de lactobacillus salivarius y usos de las mismas | |
| MX395076B (es) | COMPOSICIÓN A BASE DE UN EXTRACTO DE BIOACTIVO DE L. fermentum PARA USARSE EN EL TRATAMIENTO DE CONDICIONES DERMATOLOGICAS HUMANAS. | |
| WO2021004958A3 (en) | Compositions comprising bacterial strains | |
| EP4364583A4 (en) | COMPOSITION WITH THREE LACTOBACILLUS SP. STRAINS AND ITS USE | |
| WO2023004415A3 (en) | Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments | |
| WO2006088481A3 (en) | Genetically engineered equine influenza virus and uses thereof | |
| MX2025006782A (es) | Degradadores de la cinasa 4 asociada al receptor de interleucina-1 (irak4) y usos de los mismos | |
| PH12018550110B1 (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
| MX2022001973A (es) | Formulaciones para la prevención o reducción de infecciones por c. difficile. | |
| ZA202306411B (en) | Novel protective barrier compositions, and uses thereof | |
| ZA202203363B (en) | Immunogenic compositions | |
| MX2022010877A (es) | Cepas bacterianas y composiciones de las mismas para uso oral en el tratamiento de infecciones virales del aparato respiratorio. | |
| ITMI20011632A0 (it) | Composizione solida contenente spore di batteri non patogeni del genere bacillus | |
| MX2020005373A (es) | Cepa vacunal de brucella modificada para el tratamiento de brucelosis. | |
| WO2022011271A3 (en) | Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses | |
| ZA202303253B (en) | Modified mycobacterium bovis vaccines | |
| MX2021012604A (es) | Nuevo inhibidor de mek para el tratamiento de infecciones virales y bacterianas. | |
| MX2023014940A (es) | Bacteriofagos contra enterococci resistentes a la vancomicina. | |
| MX2023007992A (es) | Compuestos cuadracíclicos fundidos, composiciones y usos de los mismos. |